Literature DB >> 7581518

Altered expression after expansion of a v-erbA transgene in transgenic mice.

C Barlow1, B Meister, U Lendahl, B Vennström.   

Abstract

Repetitive DNA is known to undergo size variations based on an increase or decrease in the number of monomer units. We describe here the spontaneous expansion of an experimentally introduced tandem array of repeats in a transgenic mouse consisting of the human beta-actin promoter fused to the viral oncogene v-erbA and an SV40 polyadenylation signal (hAP/v-erbA). The expansion of the transgene was identified during routine screening of transgenic offspring for heterozygosity or homozygosity in one founder line. The control heterozygote genome consisted of the hAP/v-erbA transgene organized as a tandem array approximately five monomer units at a single chromosomal locus. The number of units increased to 20-21 copies, and germline transmission of the expanded units was stable for at least two generations. The majority of animals carrying the expanded monomer units retained their RNA expression patterns; however, some of these animals had drastically reduced expression levels. We discuss the possibility that expansion of repeated units may provide a mechanism by which the expression of a deleterious transgene is reduced.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581518     DOI: 10.1007/BF01973756

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  34 in total

1.  Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.

Authors:  G M Wahl; R A Padgett; G R Stark
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

2.  Methylation and imprinting: from host defense to gene regulation?

Authors:  D P Barlow
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

3.  Simple repeat DNA is not replicated simply.

Authors:  R I Richards; G R Sutherland
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

4.  Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion.

Authors:  D Wöhrle; I Hennig; W Vogel; P Steinbach
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

5.  Gene amplification in methotrexate-resistant mouse cells. II. Rearrangement and amplification of non-dihydrofolate reductase gene sequences accompany chromosomal changes.

Authors:  C J Bostock; C Tyler-Smith
Journal:  J Mol Biol       Date:  1981-12-05       Impact factor: 5.469

6.  Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes.

Authors:  D A Haber; R T Schimke
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

7.  Bovine papillomavirus genome elicits skin tumours in transgenic mice.

Authors:  M Lacey; S Alpert; D Hanahan
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

8.  Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences.

Authors:  J Brennand; A C Chinault; D S Konecki; D W Melton; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.

Authors:  J M Trent; R N Buick; S Olson; R C Horns; R T Schimke
Journal:  J Clin Oncol       Date:  1984-01       Impact factor: 44.544

10.  Evidence of founder chromosomes in fragile X syndrome.

Authors:  R I Richards; K Holman; K Friend; E Kremer; D Hillen; A Staples; W T Brown; P Goonewardena; J Tarleton; C Schwartz
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

View more
  1 in total

1.  Stable long-term germ-line transmission of transgene integration sites in mice.

Authors:  B Aigner; M Fleischmann; M Müller; G Brem
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.